Purchases and Sales Made in Q4 2024 in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX) during Q4 2024. The information is specifically focused on institutions that hold shares of EAGLE PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Simplex Trading, LLC
|
BUY
|
- |
9.81K+ 117.38% |
$3.43K - $34.9K
|
18.2K
$25.4K
|
|
|
Feb 13, 2025
Q4 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
1.16K+ 5.16% |
$405 - $4.12K
|
23.6K
$33K
|
|
|
Feb 07, 2025
Q4 2024
|
Farther Finance Advisors, LLC
San Francisco, CA |
SELL
|
- |
-29- 45.31% |
$10.1 - $103
|
35
$49
|
|
|
Feb 13, 2025
Q4 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-150- 4.21% |
$52.5 - $534
|
3.41K
$4.78K
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-810- 5.38% |
$284 - $2.88K
|
14.2K
$19.9K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-192KClosed |
$67.3K - $684K
|
0
$0
|